CURRENT NEWS
"CSI is characterized as being a laboratory with very accessible personnel."
A Puerto Rico client shares her experience of working with CSI…
Dr. Steve Kargas, Director of Surgical Pathology, Earns FACHE Certification
CSI Laboratories is proud to announce that Director of Surgical…
CSI Laboratories Announces Construction of New Cancer Diagnostics Laboratory in Florida
CSI Laboratories, a national cancer diagnostics laboratory based…
New Molecular Testing Guidelines for Lung Cancer Patients
A collaboration between the College of American Pathologists…
What is the Genius MMAP protocol?
Genius MMAP
CSI’s Multiple Myeloma Assessment Protocol…
Immunotherapy Available for Tumors Identified as dMMR or MSI-H
Patients with unresectable or metastatic solid tumors identified…
Updated ASCO Guidelines for Stage IV NSCLC Use PD-L1 Testing to Assist in Selection of Therapy
CSI Laboratories offers PD-L1 testing which aids in identifying…
CSI Laboratories Partnership with Avalon Healthcare Solutions to Benefit Patients in South Carolina
CSI Laboratories today announced that they have entered into…
Join Us @ Booth #640 in San Antonio for USCAP 2017
Join us at USCAP 2017 in San Antonio, Tx, March 6-8.…
CSI Laboratories’ C•RESULTS Colorectal Carcinoma Panel Mirrors Recently Published Recommendations by ASCP, CAP, AMP, and ASCO
The recent publication of recommendations for molecular biomarkers…